Related Experiment Video
Updated: Jan 18, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Targeting the endocannabinoid-eicosanoid axis to treat pain: Promise and pitfalls
1Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
Abstract:
In this issue of Cell Chemical Biology, Tufail et al.1 demonstrate that the peripheral diacylglycerol lipase α/β inhibitor A1480LS exerts potent anti-inflammatory and analgesic effects by blocking 2-arachidonoylglycerol synthesis and reducing arachidonate-derived eicosanoid production. However, potential risks from altered protein kinase C signaling due to elevated diacylglycerols warrant further evaluation in future therapeutic applications.
Related Concept Videos
Analgesia and Pain Management
Nociception
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pain

